Life Insurance
Consensus Index

AI Consensus Fit Review

Mutual of Omaha Life Insurance Fit Review for People With Heart Disease

Mutual of Omaha is a good, but not automatically best, fit for a U.S.

Research: 2026-09-227 usable platform responsesRead the methodology ↗

Share

Answer Capsule

Mutual of Omaha is a good, but not automatically best, fit for a U.S. consumer with heart disease who needs modest permanent coverage and may not qualify for medically underwritten insurance. Six of the seven included platforms named Mutual of Omaha during ranking discovery, and six returned a usable fit assessment. The strongest reason to consider it is a guaranteed-issue whole life path with no health questions or medical exam, plus simplified-issue and term alternatives for more stable cardiac histories. The main limitation is that guaranteed-issue coverage is capped at roughly $25,000, carries a two-year graded benefit for natural death, and costs more per dollar than medically underwritten coverage.

Research Snapshot

FieldFinding
Platform mentions in ranking stage6 of 7 included platforms (anthropic, deepseek, google, kimi, openai, perplexity)
Share of included platform responses85.7%
Average listed rank5.5
Best listed rank4
Relevant product/model/planGuaranteed Whole Life / Living Promise Final Expense, with Term Life Express and fully underwritten alternatives evaluated separately
Overall use-case fitGood (platform fit ratings: strong for grok; good for anthropic, google, kimi, openai; mixed for perplexity)
Research date2026-09-22

Why Mutual of Omaha Qualified for This Study

Questions This Section Answers

  • Why did Mutual of Omaha qualify for this heart disease life insurance study?
  • How many AI platforms named Mutual of Omaha for life insurance with heart disease?

Mutual of Omaha qualified because six of the seven included platforms named it during ranking discovery, and six platforms returned a usable fit assessment for this use case. It was the third-ranked finalist overall, with an average listed rank of 5.5 and a best listed rank of 4 (anthropic, google). The company was named by anthropic, deepseek, google, kimi, openai, and perplexity.

The qualification is driven by product structure rather than a single product. Platforms repeatedly pointed to a guaranteed-issue whole life path for applicants who cannot pass medical underwriting, a simplified-issue final expense product with level and graded tiers, and a simplified-issue term product for larger face amounts [1]. Mutual of Omaha also publishes consumer-facing guidance specifically about life insurance after a heart attack, which several platforms treated as evidence the company actively markets to impaired-risk shoppers [4].

This is a niche fit review, not a broad company review. It evaluates Mutual of Omaha only for the Life Insurance for People With Heart Disease use case. For the full field of carriers assessed for this buyer, see the Life Insurance for People With Heart Disease consensus index.

The Product, Model, Plan, or Service Most Relevant to Life Insurance for People With Heart Disease

Questions This Section Answers

  • Which Mutual of Omaha plan is most relevant for a buyer with heart disease who needs final expense coverage?
  • Is Mutual of Omaha Guaranteed Whole Life the right product for someone with severe or recent heart disease?
  • Should a buyer with stable heart disease choose Mutual of Omaha Living Promise or Term Life Express?

The most relevant product is Guaranteed Whole Life, the guaranteed-issue whole life policy, with Living Promise Final Expense as the simplified-issue alternative and Term Life Express as the simplified-issue term option for larger face amounts. Platforms did not converge on a single product name, and that disagreement is itself a finding.

Guaranteed Whole Life is the fallback path. Official Mutual of Omaha material states the product is available for specified age ranges, provides $2,000–$25,000 of coverage, and is underwritten by United of Omaha Life Insurance Company [7]. The same official eligibility material states guaranteed whole life policies do not require a medical exam or health questions [8]. Platforms describe the age range as 45–85, with a New York range of 50–75 [7].

Living Promise is the simplified-issue final expense product. It is not guaranteed acceptance: it uses a health questionnaire, height/weight ratio, and medication history, and applicants can be declined [11]. Platforms report level and graded benefit tiers, with face amounts cited between $2,000 and $40,000, and up to $50,000 in some states [16].

Term Life Express is the simplified-issue term product. Producer material describes simplified underwriting with no blood or urine, no paramed exam, and no lengthy health inquiries [19]. Reported issue ages are 18–75, with face amounts of $25,000–$300,000 at ages 18–50, $25,000–$250,000 at ages 51–60, and $25,000–$150,000 at ages 61–75 [20]. One platform noted a conflict: maximum issue age is stated as 75 in one source but 80 in general company guidance [20].

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about Mutual of Omaha for heart disease applicants?
  • Does Mutual of Omaha offer a no-exam life insurance option for people with heart disease?

Platforms agreed on four points, though not unanimously across all seven.

First, Mutual of Omaha offers a genuine guaranteed-issue path. Official material confirms no medical exam or health questions for the guaranteed whole life product [21], and platforms across anthropic, grok, kimi, openai, and perplexity described it the same way [22].

Second, the guaranteed-issue product carries a two-year graded benefit for natural death. Official material states that for nonaccidental death during the first two years, the beneficiary receives 110% of premiums paid, while accidental death during that period receives the selected face amount, and full benefits apply after two years [27]. Independent reviews repeat the same structure, with one source describing it as premiums plus 10% interest [28].

Third, coverage is capped at a modest face amount. The official product page lists $2,000–$25,000, or $5,000–$25,000 in Washington [25]. Platforms consistently described this as final-expense coverage rather than income replacement [25].

Fourth, premiums are fixed after issue and are based principally on age, sex, and selected death benefit rather than health [27]. One platform reported a fixed cash value interest rate of 5.66% [32].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • Do AI platforms disagree about whether Mutual of Omaha Living Promise is guaranteed issue or simplified issue?
  • Is Mutual of Omaha's heart disease underwriting outcome for a specific diagnosis publicly verifiable?

Platforms disagreed on several material points, and buyers should treat these as open questions rather than settled facts.

The clearest disagreement is whether Living Promise is guaranteed issue. Multiple independent reviews state plainly that Living Promise is simplified issue, not guaranteed issue, and that it distinguishes Mutual of Omaha from carriers like Colonial Penn or Globe Life [33]. One platform's ranking-stage description grouped "Living Promise Final Expense / Guaranteed Acceptance Whole Life" together [36], which blurs a distinction that matters to a buyer with heart disease.

Coverage maximums conflict. One source reported Living Promise up to $40,000 while another noted conflicting higher ceilings, and the exact maximum should be verified in writing [37]. Google's research cited $40,000 for level benefits and up to $50,000 in some states, with graded benefits capped at $20,000 [38].

The graded-benefit percentage conflicts slightly. One source states 110% of premiums for natural death in the first two years [40]; another states 110–120% and notes the exact percentage may vary by plan year or state [41].

Heart-disease-specific underwriting rules are not publicly established. Official pages give general age, coverage, and benefit information but not heart-disease-specific approval criteria (openai). Agent underwriting materials indicate applicants with coronary artery disease, heart attack, coronary bypass surgery, angioplasty, cardiomyopathy, irregular heart rhythm, or valvular heart disease with surgical repair may be ineligible for some simplified or underwritten coverage paths [42]. One platform reported that a heart condition, treatment, or procedure within the last two years triggers graded or decline consideration for the level tier [43], and another reported a two-year lookback on major cardiac history for the level benefit [44].

No independent evidence was identified that compares Mutual of Omaha's heart-disease acceptance rates, premiums, claims outcomes, or competitiveness against other carriers (openai). That gap is a limitation of this review, not a finding about the company.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What features make Mutual of Omaha useful for a buyer with heart disease who may be declined elsewhere?
  • How much coverage can a Mutual of Omaha guaranteed issue policy provide for someone with heart disease?

The features that matter most for this buyer are guaranteed acceptance, no medical exam, fixed premiums, and a tiered product ladder that lets an applicant move from simplified issue to guaranteed issue if declined.

Guaranteed acceptance is the core capability. The guaranteed whole life product does not require health questions or a medical exam, and acceptance is guaranteed within the stated age range [45]. For a buyer with severe or recent cardiac disease, this removes the risk of outright declination.

The product ladder is the second capability. A buyer with stable, well-documented heart disease can be evaluated for Living Promise level benefit, then Living Promise graded benefit, then Guaranteed Whole Life, and separately for Term Life Express if larger coverage is needed [48]. One platform described this as a clear pathway from guaranteed issue to simplified issue to fully underwritten term, making it versatile across cardiac severity levels (kimi).

Term Life Express adds capacity. Simplified underwriting with no blood, urine, or paramed exam is available, with face amounts up to $300,000 at younger ages [51]. However, company guidance states that multiple impairments resulting in a rating greater than Table 4 are declined from Express products [53], so complex cardiac cases may not qualify.

Additional reported features include a 30-day free-look period [54], an accelerated death benefit rider on some products for terminal illness or nursing home confinement [55], and a conversion option on Term Life Express policies (anthropic). Cash value growth is described as modest [56].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does Mutual of Omaha guaranteed whole life cost per month for a 55-year-old with heart disease?
  • Are there setup, cancellation, or policy fees with Mutual of Omaha life insurance for heart disease applicants?

Pricing is not publicly determinable for a specific buyer without age, state, sex classification, benefit amount, and product selection. Published figures are illustrative examples, not personalized quotes.

Official illustrative guaranteed-whole-life rates list $10,000 of coverage at $32.46 per month for a 50-year-old female and $42.81 per month for a 50-year-old male [57]. Independent sources report a 55-year-old female paying about $39.96 per month for $15,000 of Living Promise coverage [58], and a 55-year-old male paying roughly $95 per month for $15,000 of guaranteed-issue coverage (grok). Another source lists $156 per month for $20,000 at age 65 for a male and $120 per month for $20,000 at age 65 for a female (kimi). Google's research cites guaranteed acceptance sample premiums for $10,000 of coverage ranging from approximately $28 to $158 for females and $36 to $157 for males depending on age [59].

These figures conflict in ways that reflect different products, ages, and states rather than a single rate. Health is stated not to affect the guaranteed-issue quote [57], while Living Promise pricing depends on the underwriting tier assigned [60].

On fees, no separate application or policy fee was identified in the reviewed official materials, and buyers should verify whether state-specific charges, rider costs, billing fees, or agent-related charges apply (openai). One platform reported no application, underwriting, or medical exam fees, with policy fees not explicitly disclosed (anthropic).

Contract terms include a two-year limited-benefit period for nonaccidental death on the guaranteed-issue product [57]. Premiums are paid through the life of the policy, with the cited material stating premiums are paid up to age 100 [57]. A 30-day free-look period is reported [62]. One platform reported a suicide clause with a two-year exclusion, one year in North Dakota and Minnesota (anthropic). Outstanding policy loans and accumulated loan interest can reduce surrender value or the death benefit (openai).

Best Suited For

Questions This Section Answers

  • Who is Mutual of Omaha best suited for among buyers with heart disease?
  • Is Mutual of Omaha a good choice for a buyer with severe heart disease who was declined elsewhere?

Mutual of Omaha is best suited for applicants ages 45–85, or 50–75 in New York, seeking approximately $2,000–$25,000 of permanent final-expense coverage who may not qualify for medically underwritten insurance [63].

It also fits applicants with moderate-to-severe or poorly documented heart disease who want an option without medical underwriting, and buyers who prioritize guaranteed acceptance and fixed premiums over a larger death benefit or the lowest cost per dollar of coverage (openai). Platforms specifically named consumers with recent or severe heart disease, such as congestive heart failure or a recent myocardial infarction, who were declined by other carriers [65].

A third fit is the bridge-coverage buyer: someone who needs protection now while stabilizing a cardiac condition for future traditional underwriting. One platform explicitly recommended Mutual of Omaha as a source for guaranteed bridge coverage, with the guidance to keep the guaranteed-issue policy in force until a new policy is active [68].

Buyers who want simplified underwriting with no medical exam and faster approval also fit, provided they can answer the health questionnaire favorably [69].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose Mutual of Omaha for life insurance with heart disease?
  • Is Mutual of Omaha a poor choice for a buyer who needs large income-replacement coverage?

Mutual of Omaha is probably not best suited for applicants who need substantial income-replacement coverage, mortgage protection, or large estate liquidity. The guaranteed-issue and final-expense products cap at $25,000 and $40,000 respectively, which is insufficient for those needs [71].

It is also a weaker fit for applicants whose heart disease is stable enough to qualify for competitively priced simplified or fully underwritten term or whole-life insurance elsewhere [72]. One platform ranked Prudential best for post-stent and post-bypass cases with two or more years of stability, John Hancock for cardiac rehab premium credits, and Banner Life for controlled hypertension and mild coronary artery disease, and did not cite Mutual of Omaha as leading for those profiles [73].

Applicants who cannot economically justify premiums during the two-year graded-benefit period are also a poor fit (openai). The same applies to buyers who need immediate full death benefit coverage but may only qualify for graded or limited-benefit underwriting (perplexity).

Buyers who want a purely digital, instant-quote experience should note that all applications require agent contact, with no instant online quotes or DIY process reported (anthropic).

When Another Option May Be Better

Questions This Section Answers

  • When is a different carrier better than Mutual of Omaha for a buyer with heart disease?
  • What should a buyer with stable heart disease compare before choosing Mutual of Omaha?

Another option may be better in five situations the platforms identified.

When the applicant had a very recent heart attack, stroke, or cardiac procedure within weeks or months and needs immediate full coverage, true guaranteed-issue carriers such as Globe Life or Colonial Penn may be worth comparing, despite higher premiums and longer waiting periods (anthropic). When the applicant needs coverage above roughly $40,000–$50,000 for family protection or mortgage coverage, Term Life Express or traditional term from other carriers such as Banner Life or Pacific Life may offer more capacity [74].

When the applicant has multiple severe comorbidities, such as diabetes, COPD, or cancer within four years plus heart disease, simplified-issue decline becomes likely and guaranteed-issue carriers or specialty high-risk brokers may be necessary (anthropic). When the applicant strongly dislikes waiting periods and prefers day-one full coverage, the Living Promise level tier is strong if the applicant qualifies, but other carriers' level-benefit options should be explored if routed to graded (anthropic).

When the applicant's ejection fraction is above 45% with 12 or more months of stability, Prudential, John Hancock, or Banner Life may be better positioned for standard or preferred rates (kimi). A licensed independent broker can obtain competing guaranteed-issue quotes, and Mutual of Omaha is not necessarily the lowest-cost option for a required face amount (openai).

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with Mutual of Omaha before signing a heart disease life insurance contract?
  • Which cardiac details determine whether Mutual of Omaha assigns a graded or level benefit?

The platform research surfaced a consistent verification list. Buyers should confirm which legal insurer and policy form will issue the policy in their state, since the cited product is underwritten by United of Omaha Life Insurance Company while New York uses a different underwriting company and eligibility range [75].

Buyers should confirm whether they are eligible for simplified or fully underwritten coverage before accepting guaranteed issue, and what cardiac records, tests, medications, and physician statements are required (openai). They should ask which exact heart-disease conditions trigger a decline, postponement, graded benefit, flat extra, or higher underwriting class (openai, perplexity).

Buyers should confirm whether the proposed policy has a two-year graded benefit and exactly how nonaccidental death, accidental death, suicide, and misrepresentation are handled [76]. They should request the personalized premium, payment duration, lapse grace period, reinstatement rule, cash value schedule, surrender value, and loan interest rate (openai).

Buyers should confirm the exact maximum face amount available for the Living Promise level benefit in their state, since sources conflict between $40,000 and $50,000 [77]. They should ask whether specific cardiac medications, such as blood thinners or anti-arrhythmics, trigger a graded or knockout decision on the simplified application (google). They should confirm whether the requested face amount is sufficient for actual final expenses and other obligations, and how the quote compares with at least two competing carriers (openai).

Final AI Consensus Verdict

Mutual of Omaha is a good, but not automatically best, fit for a U.S. consumer with heart disease. Six of the seven included platforms named it during ranking discovery, and six returned a usable fit assessment. Platform fit ratings were strong for grok; good for anthropic, google, kimi, and openai; and mixed for perplexity. That spread is not unanimous, and platform agreement does not prove product quality.

The strongest reason to consider it is the guaranteed-issue whole life path: no health questions, no medical exam, fixed premiums, and acceptance within the stated age range [78]. The main limitations are the roughly $25,000 guaranteed-issue cap, the two-year graded benefit for natural death, higher cost per dollar than medically underwritten coverage, and state-specific variation in forms and availability [81].

A consumer with stable, well-documented heart disease should first compare simplified and fully underwritten alternatives through an independent broker before choosing guaranteed issue (openai). A consumer with severe or recent cardiac disease who needs modest final-expense coverage has a practical, predictable option here.

How This Review Was Produced

This review was produced from platform-reported research collected on 2026-09-22. Seven platforms were configured for the study, and six returned a usable fit assessment for this use case. Platform mentions in the ranking stage count only platforms that named Mutual of Omaha during ranking discovery, which was six of seven.

Each platform's response included its own citations, which are reproduced as parenthetical citation IDs in this article. Those citations are platform-reported evidence, not independently verified facts. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Where a platform supplied no citation for a factual claim, the claim is labeled platform-reported or unverified.

Methodology Limitations

Several limitations apply. Six of seven included platforms returned a usable fit assessment, so the fit findings are not unanimous and should not be described as such. One platform (deepseek) was configured with search disabled, and its response was not part of the usable fit assessment set.

Platform-reported research dates are provenance metadata and do not independently prove freshness. Published rate examples and ranges may be state-specific, may change, and are not personalized quotes. The official pages give general age, coverage, and benefit information but not heart-disease-specific approval criteria.

No independent evidence was identified that compares Mutual of Omaha's heart-disease acceptance rates, premiums, claims outcomes, or competitiveness against other carriers. Conflicting product names, coverage maximums, graded-benefit percentages, and issue ages were not resolved by guessing; buyers should verify them directly. The deterministic identity audit noted that official-site retrieval failed for one or more mentions, and that a product-labeled company mention was merged using matching company-name and supplied-domain signatures.

Sources

Company-Owned Sources

Independent Sources

Other Sources

  • Mutual of Omaha Term Life Express: No-Exam Term Life: https://asurgo.com/insurance-reviews/mutual-of-omaha/term-life-express/
  • United of Omaha Life Insurance Company - insdesign.com: https://insdesign.com/wp-content/uploads/FinalExpense-UW-Mutual-of-Omaha.pdf
  • Additional AI research evidence82 records
    1. AI research evidence record openai:c1
    2. AI research evidence record anthropic:23-13
    3. AI research evidence record perplexity:c1
    4. AI research evidence record anthropic:1-1
    5. AI research evidence record perplexity:c5
    6. AI research evidence record kimi:mutualofomaha-heart-attack
    7. AI research evidence record openai:c1
    8. AI research evidence record openai:c2
    9. AI research evidence record anthropic:11-5
    10. AI research evidence record grok:0
    11. AI research evidence record anthropic:37-3
    12. AI research evidence record anthropic:37-4
    13. AI research evidence record anthropic:38-1
    14. AI research evidence record anthropic:38-2
    15. AI research evidence record anthropic:42-6
    16. AI research evidence record anthropic:23-13
    17. AI research evidence record google:1.3.9
    18. AI research evidence record google:2.2.5
    19. AI research evidence record anthropic:28-1
    20. AI research evidence record anthropic:30-5
    21. AI research evidence record openai:c2
    22. AI research evidence record anthropic:11-5
    23. AI research evidence record grok:0
    24. AI research evidence record kimi:mozdex-best-2026
    25. AI research evidence record openai:c1
    26. AI research evidence record perplexity:c5
    27. AI research evidence record openai:c3
    28. AI research evidence record anthropic:14-1
    29. AI research evidence record google:2.2.6
    30. AI research evidence record anthropic:23-13
    31. AI research evidence record kimi:moneygeek-heart-2026
    32. AI research evidence record anthropic:13-9
    33. AI research evidence record anthropic:37-3
    34. AI research evidence record anthropic:38-1
    35. AI research evidence record anthropic:42-6
    36. AI research evidence record grok:5
    37. AI research evidence record anthropic:23-13
    38. AI research evidence record google:1.3.9
    39. AI research evidence record google:2.2.5
    40. AI research evidence record anthropic:14-1
    41. AI research evidence record openai:c3
    42. AI research evidence record perplexity:c6
    43. AI research evidence record anthropic:40-1
    44. AI research evidence record google:1.3.3
    45. AI research evidence record openai:c2
    46. AI research evidence record anthropic:11-5
    47. AI research evidence record grok:0
    48. AI research evidence record anthropic:23-13
    49. AI research evidence record google:1.3.9
    50. AI research evidence record perplexity:c1
    51. AI research evidence record anthropic:28-1
    52. AI research evidence record anthropic:30-5
    53. AI research evidence record anthropic:32-1
    54. AI research evidence record anthropic:13-4
    55. AI research evidence record anthropic:24-6
    56. AI research evidence record anthropic:13-9
    57. AI research evidence record openai:c3
    58. AI research evidence record anthropic:12-1
    59. AI research evidence record google:1.2.5
    60. AI research evidence record anthropic:23-13
    61. AI research evidence record anthropic:14-1
    62. AI research evidence record anthropic:13-4
    63. AI research evidence record openai:c1
    64. AI research evidence record anthropic:11-5
    65. AI research evidence record grok:0
    66. AI research evidence record kimi:mozdex-best-2026
    67. AI research evidence record google:1.2.8
    68. AI research evidence record kimi:mozdex-application-2026
    69. AI research evidence record anthropic:28-1
    70. AI research evidence record anthropic:37-4
    71. AI research evidence record anthropic:23-13
    72. AI research evidence record kimi:ogletree-2026
    73. AI research evidence record kimi:lifeinsureguide-2026
    74. AI research evidence record kimi:lifeinsureguide-2026
    75. AI research evidence record openai:c1
    76. AI research evidence record anthropic:14-1
    77. AI research evidence record google:1.3.9
    78. AI research evidence record openai:c2
    79. AI research evidence record anthropic:11-5
    80. AI research evidence record grok:0
    81. AI research evidence record openai:c1
    82. AI research evidence record openai:c3

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 22, 2026
Platforms analyzed
7
Source records
48
Ranking mentions
6 of 7
Platform share
86%
Final consensus rank
#3

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

26 independent · 20 company-owned · 2 unclear

Evidence support

39 direct · 8 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

de984b86bea77d7ac5f7e2ca0b00da140566e012f292d31675a9357dc1f8020f